- Some friends work there and they are nice and smart
- Cheap enough for a high tech promising growth stock:
railing P/E 17.69 Forward P/E 1 14.57
I just placed this order, with a limit well above after hours price and yesterday closing:
| Buy | 5 | BIIB | BIOGEN INC | Limit $303.00 | 301.01 | 302.82 | Day |
Profitability
| Profit Margin | 33.97% |
| Operating Margin (ttm) | 49.26% |
Management Effectiveness
| Return on Assets (ttm) | 18.08% |
| Return on Equity (ttm) | 32.25% |
Income Statement
| Revenue (ttm) | 11.24B |
| Revenue Per Share (ttm) | 50.47 |
| Quarterly Revenue Growth (yoy) | 11.70% |
| Gross Profit (ttm) | 9.52B |
| EBITDA | 6.15B |
| Net Income Avi to Common (ttm) | 3.82B |
| Diluted EPS (ttm) | 17.12 |
| Quarterly Earnings Growth (yoy) | 13.20% |
Balance Sheet
| Total Cash (mrq) | 3.8B |
| Total Cash Per Share (mrq) | 17.33 |
| Total Debt (mrq) | 6.54B |
| Total Debt/Equity (mrq) | 57.38 |
| Current Ratio (mrq) | 2.96 |
| Book Value Per Share (mrq) | 52.04 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.9B |
| Levered Free Cash Flow (ttm) | 2.98B |
BUY, SELL, KEEP 
Leave a comment